Matthew Chang

Executive Director, National University of Singapore

Executive Director, Singapore National Centre for Engineering Biology; Director, Singapore Consortium for Synthetic Biology; Wilmar-NUS Corporate Laboratory; NUS Synthetic Biology for Clinical and Technological Innovation. Dean's Chair in Medicine and Associate Professor, Yong Loo Lin School of Medicine, National University of Singapore. Co-founder, Asian Synthetic Biology Association; Global Biofoundry Alliance. Advisory member, Synthetic Biology Africa; CSIRO Synthetic Biology Future Science Platform; E.U. Horizon 2020-MADONNA; Synthetic Biology Open Language, among others. International member, U.S. Synthetic Biology Research Center; U.S. Engineering Biology Research Consortium, E.U. BioRoboost, among others. Recipient of honors and awards, National Research Foundation of Singapore Investigatorship Award; NUHS-Mochtar Riady Pinnacle Research Excellence Award; Korean Federation of Science and Technology Societies Presidential Award; U.S. EPA Scientific and Technological Achievement Award, among others. Chair, 15th Metabolic Engineering Conference; 7th International Meeting on Synthetic Biology. Editor and editorial board member, 15 biotechnology journals. Author of 130 publications and inventor of 15 patents, with over 300 media recognitions, in the fields of biotechnology and synthetic biology. Mentor of over 50 high school and undergraduate students, 20 Ph.D. students and 40 research scientists. http://SynCTI.org/

关于我们

加入我们

  • 登录
  • 成为我们的合作伙伴
  • 成为我们的会员
  • 订阅我们的新闻稿
  • 联系我们

快捷链接

语言版本

隐私政策和服务条款

站点地图

© 2024 世界经济论坛